The updated American College of Cardiology/American Heart Association (ACC/AHA) Guideline on the Treatment of Blood Cholesterol (GTBC) has been long-awaited since the latest update of the Adult Treatment Panel III (ATP III) guidelines in 2004. The updated GTBC recommends a significant paradigm shift in lipid-lowering drug therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction, which has led to questions regarding their content and their implementation.
Clinical Predictors of Increased Perioperative Cardiovascular Risk (Myocardial Infarction, Heart Failure, Death)
- Unstable coronary syndromes
- Acute or recent MI* with evidence of important ischemic risk by clinical symptoms or noninvasive study
- Unstable or severe† angina (Canadian class III or IV) Continue reading
Cardiovascular Major Risk Factors